Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 41 entries
Sorted by: Best Match Show Resources per page
Peer teaching as an educational tool in Pharmacy schools; fruitful or futile.

Currents in pharmacy teaching & learning

Aburahma MH, Mohamed HM.
PMID: 29233388
Curr Pharm Teach Learn. 2017 Nov;9(6):1170-1179. doi: 10.1016/j.cptl.2017.07.026. Epub 2017 Sep 01.

BACKGROUND: In the past decade, various health care programs have implemented diverse types of peer-assisted learning (PAL) programs, in particularly peer teaching (PT), due to their reported benefits for students (both those undertaking teaching and those being taught), teachers,...

Cite
Aburahma MH, Mohamed HM. Peer teaching as an educational tool in Pharmacy schools; fruitful or futile. Curr Pharm Teach Learn. 2017;9(6):1170-1179doi: 10.1016/j.cptl.2017.07.026.
Aburahma, M. H., & Mohamed, H. M. (2017). Peer teaching as an educational tool in Pharmacy schools; fruitful or futile. Currents in pharmacy teaching & learning, 9(6), 1170-1179. https://doi.org/10.1016/j.cptl.2017.07.026
Aburahma, Mona Hassan, and Mohamed, Heba Moustafa. "Peer teaching as an educational tool in Pharmacy schools; fruitful or futile." Currents in pharmacy teaching & learning vol. 9,6 (2017): 1170-1179. doi: https://doi.org/10.1016/j.cptl.2017.07.026
Aburahma MH, Mohamed HM. Peer teaching as an educational tool in Pharmacy schools; fruitful or futile. Curr Pharm Teach Learn. 2017 Nov;9(6):1170-1179. doi: 10.1016/j.cptl.2017.07.026. Epub 2017 Sep 01. PMID: 29233388.
Copy Download .nbib Format: NLM
Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis.

Journal of intensive care

Zayed YZM, Aburahma AMY, Barbarawi MO, Hamid K, Banifadel MRN, Rashdan L, Bachuwa GI.
PMID: 30140441
J Intensive Care. 2018 Aug 17;6:51. doi: 10.1186/s40560-018-0320-x. eCollection 2018.

OBJECTIVES: Intravenous fluids are one of the most used medical therapy for patients, especially critically ill patients. We conducted a meta-analysis comparing between balanced crystalloids and normal saline in critically ill patients and its effect on various clinical outcomes.DESIGN:...

Cite
Zayed YZM, Aburahma AMY, Barbarawi MO, et al. Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis. J Intensive Care. 2018;6:51doi: 10.1186/s40560-018-0320-x.
Zayed, Y. Z. M., Aburahma, A. M. Y., Barbarawi, M. O., Hamid, K., Banifadel, M. R. N., Rashdan, L., & Bachuwa, G. I. (2018). Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis. Journal of intensive care, 651. https://doi.org/10.1186/s40560-018-0320-x
Zayed, Yazan Z M, et al. "Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis." Journal of intensive care vol. 6 (2018): 51. doi: https://doi.org/10.1186/s40560-018-0320-x
Zayed YZM, Aburahma AMY, Barbarawi MO, Hamid K, Banifadel MRN, Rashdan L, Bachuwa GI. Balanced crystalloids versus isotonic saline in critically ill patients: systematic review and meta-analysis. J Intensive Care. 2018 Aug 17;6:51. doi: 10.1186/s40560-018-0320-x. eCollection 2018. PMID: 30140441; PMCID: PMC6098635.
Copy Download .nbib Format: NLM
Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials.

Journal of community hospital internal medicine perspectives

Barbarawi M, Kheiri B, Zayed Y, Aburahma A, Osman M, Barbarawi O, Hicks M, Hassan M, Alkotob ML, Bachuwa G.
PMID: 30788068
J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):9-17. doi: 10.1080/20009666.2018.1562853. eCollection 2019.

No abstract available.

Cite
Barbarawi M, Kheiri B, Zayed Y, et al. Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials. J Community Hosp Intern Med Perspect. 2019;9(1):9-17doi: 10.1080/20009666.2018.1562853.
Barbarawi, M., Kheiri, B., Zayed, Y., Aburahma, A., Osman, M., Barbarawi, O., Hicks, M., Hassan, M., Alkotob, M. L., & Bachuwa, G. (2019). Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials. Journal of community hospital internal medicine perspectives, 9(1), 9-17. https://doi.org/10.1080/20009666.2018.1562853
Barbarawi, Mahmoud, et al. "Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials." Journal of community hospital internal medicine perspectives vol. 9,1 (2019): 9-17. doi: https://doi.org/10.1080/20009666.2018.1562853
Barbarawi M, Kheiri B, Zayed Y, Aburahma A, Osman M, Barbarawi O, Hicks M, Hassan M, Alkotob ML, Bachuwa G. Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials. J Community Hosp Intern Med Perspect. 2019 Feb 11;9(1):9-17. doi: 10.1080/20009666.2018.1562853. eCollection 2019. PMID: 30788068; PMCID: PMC6374928.
Copy Download .nbib Format: NLM
Invited Commentary.

Journal of the American College of Surgeons

AbuRahma AF.
PMID: 33771321
J Am Coll Surg. 2021 Apr;232(4):635. doi: 10.1016/j.jamcollsurg.2020.12.054.

No abstract available.

Cite
AbuRahma AF. Invited Commentary. J Am Coll Surg. 2021;232(4):635doi: 10.1016/j.jamcollsurg.2020.12.054.
AbuRahma, A. F. (2021). Invited Commentary. Journal of the American College of Surgeons, 232(4), 635. https://doi.org/10.1016/j.jamcollsurg.2020.12.054
AbuRahma, Ali F. "Invited Commentary." Journal of the American College of Surgeons vol. 232,4 (2021): 635. doi: https://doi.org/10.1016/j.jamcollsurg.2020.12.054
AbuRahma AF. Invited Commentary. J Am Coll Surg. 2021 Apr;232(4):635. doi: 10.1016/j.jamcollsurg.2020.12.054. PMID: 33771321.
Copy Download .nbib Format: NLM
Reply.

Journal of vascular surgery

AbuRahma AF, Darling RC.
PMID: 34598762
J Vasc Surg. 2021 Oct;74(4):1432-1433. doi: 10.1016/j.jvs.2021.06.029.

No abstract available.

Cite
AbuRahma AF, Darling RC. Reply. J Vasc Surg. 2021;74(4):1432-1433doi: 10.1016/j.jvs.2021.06.029.
AbuRahma, A. F., & Darling, R. C. (2021). Reply. Journal of vascular surgery, 74(4), 1432-1433. https://doi.org/10.1016/j.jvs.2021.06.029
AbuRahma, Ali F, and Darling, R Clement. "Reply." Journal of vascular surgery vol. 74,4 (2021): 1432-1433. doi: https://doi.org/10.1016/j.jvs.2021.06.029
AbuRahma AF, Darling RC. Reply. J Vasc Surg. 2021 Oct;74(4):1432-1433. doi: 10.1016/j.jvs.2021.06.029. PMID: 34598762.
Copy Download .nbib Format: NLM
Antiphospholipid Antibody Induced by Nivolumab.

Case reports in hematology

Aburahma A, Aljariri Alhesan N, Elounais F, Abu Sitta E.
PMID: 29581905
Case Rep Hematol. 2018 Jan 11;2018:3106852. doi: 10.1155/2018/3106852. eCollection 2018.

Nivolumab is a monoclonal antibody against the programmed death protein 1 and is used for patients with advanced melanoma. It is associated with potentially immune-related adverse events, including disorders of the skin, GI tract, and the thyroid; these disorders...

Cite
Aburahma A, Aljariri Alhesan N, Elounais F, et al. Antiphospholipid Antibody Induced by Nivolumab. Case Rep Hematol. 2018;2018:3106852doi: 10.1155/2018/3106852.
Aburahma, A., Aljariri Alhesan, N., Elounais, F., & Abu Sitta, E. (2018). Antiphospholipid Antibody Induced by Nivolumab. Case reports in hematology, 20183106852. https://doi.org/10.1155/2018/3106852
Aburahma, Ahmed, et al. "Antiphospholipid Antibody Induced by Nivolumab." Case reports in hematology vol. 2018 (2018): 3106852. doi: https://doi.org/10.1155/2018/3106852
Aburahma A, Aljariri Alhesan N, Elounais F, Abu Sitta E. Antiphospholipid Antibody Induced by Nivolumab. Case Rep Hematol. 2018 Jan 11;2018:3106852. doi: 10.1155/2018/3106852. eCollection 2018. PMID: 29581905; PMCID: PMC5821982.
Copy Download .nbib Format: NLM
Invited commentary.

Journal of vascular surgery

AbuRahma AF.
PMID: 29685250
J Vasc Surg. 2018 May;67(5):1583-1584. doi: 10.1016/j.jvs.2017.04.045.

No abstract available.

Cite
AbuRahma AF. Invited commentary. J Vasc Surg. 2018;67(5):1583-1584doi: 10.1016/j.jvs.2017.04.045.
AbuRahma, A. F. (2018). Invited commentary. Journal of vascular surgery, 67(5), 1583-1584. https://doi.org/10.1016/j.jvs.2017.04.045
AbuRahma, Ali F. "Invited commentary." Journal of vascular surgery vol. 67,5 (2018): 1583-1584. doi: https://doi.org/10.1016/j.jvs.2017.04.045
AbuRahma AF. Invited commentary. J Vasc Surg. 2018 May;67(5):1583-1584. doi: 10.1016/j.jvs.2017.04.045. PMID: 29685250.
Copy Download .nbib Format: NLM
A survey of therapeutic drug monitoring services in Malaysia.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

Ab Rahman AF, Ahmed Abdelrahim HE, Mohamed Ibrahim MI.
PMID: 23960816
Saudi Pharm J. 2013 Jan;21(1):19-24. doi: 10.1016/j.jsps.2012.01.002. Epub 2012 Jan 14.

In Malaysia, therapeutic drug monitoring (TDM) service was started in the 1980s. Since then, the number of hospitals that offer the service has increased. In this paper, we report the findings of a nationwide survey describing the practice of...

Cite
Ab Rahman AF, Ahmed Abdelrahim HE, Mohamed Ibrahim MI. A survey of therapeutic drug monitoring services in Malaysia. Saudi Pharm J. 2012;21(1):19-24doi: 10.1016/j.jsps.2012.01.002.
Ab Rahman, A. F., Ahmed Abdelrahim, H. E., & Mohamed Ibrahim, M. I. (2013). A survey of therapeutic drug monitoring services in Malaysia. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 21(1), 19-24. https://doi.org/10.1016/j.jsps.2012.01.002
Ab Rahman, Ab Fatah, et al. "A survey of therapeutic drug monitoring services in Malaysia." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society vol. 21,1 (2013): 19-24. doi: https://doi.org/10.1016/j.jsps.2012.01.002
Ab Rahman AF, Ahmed Abdelrahim HE, Mohamed Ibrahim MI. A survey of therapeutic drug monitoring services in Malaysia. Saudi Pharm J. 2013 Jan;21(1):19-24. doi: 10.1016/j.jsps.2012.01.002. Epub 2012 Jan 14. PMID: 23960816; PMCID: PMC3744941.
Copy Download .nbib Format: NLM
Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid.

Scientia pharmaceutica

Aburahma MH, El-Laithy HM, Hamza Yel-S.
PMID: 21179352
Sci Pharm. 2010 Apr-Jun;78(2):363-79. doi: 10.3797/scipharm.0912-04. Epub 2010 May 17.

The demand for sublingual tablets has been growing during the previous decades especially for drugs with extensive hepatic first-pass metabolism. Vinpocetine, a widely used neurotropic agent, has low oral bioavailability due to its poor aqueous solubility and marked first-pass...

Cite
Aburahma MH, El-Laithy HM, Hamza Yel-S. Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid. Sci Pharm. 2010;78(2):363-79doi: 10.3797/scipharm.0912-04.
Aburahma, M. H., El-Laithy, H. M., & Hamza, Y. e. l. -. S. (2010). Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid. Scientia pharmaceutica, 78(2), 363-79. https://doi.org/10.3797/scipharm.0912-04
Aburahma, Mona H, et al. "Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid." Scientia pharmaceutica vol. 78,2 (2010): 363-79. doi: https://doi.org/10.3797/scipharm.0912-04
Aburahma MH, El-Laithy HM, Hamza Yel-S. Preparation and in vitro/in vivo characterization of porous sublingual tablets containing ternary kneaded solid system of vinpocetine with î-cyclodextrin and hydroxy Acid. Sci Pharm. 2010 Apr-Jun;78(2):363-79. doi: 10.3797/scipharm.0912-04. Epub 2010 May 17. PMID: 21179352; PMCID: PMC3002799.
Copy Download .nbib Format: NLM
Commentary. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older.

Perspectives in vascular surgery and endovascular therapy

AbuRahma AF.
PMID: 17460854
Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):92-4.

No abstract available.

Cite
AbuRahma AF. Commentary. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older. Perspect Vasc Surg Endovasc Ther. 2007;19(1):92-4
AbuRahma, A. F. (2007). Commentary. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older. Perspectives in vascular surgery and endovascular therapy, 19(1), 92-4.
AbuRahma, Ali F. "Commentary. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older." Perspectives in vascular surgery and endovascular therapy vol. 19,1 (2007): 92-4.
AbuRahma AF. Commentary. Advancements in carotid stenting leading to reductions in perioperative morbidity among patients 80 years and older. Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):92-4. PMID: 17460854.
Copy Download .nbib Format: NLM
Predictors of D-Dimer Utilization in Patients Presenting With Limb Swelling in a High-Volume Tertiary Care Center.

Journal of vascular surgery. Venous and lymphatic disorders

Mousa A, Broce M, Kali M, Barsoum E, Mahrous R, AbuRahma AF.
PMID: 26993724
J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):130. doi: 10.1016/j.jvsv.2014.10.038. Epub 2014 Dec 15.

No abstract available.

Cite
Mousa A, Broce M, Kali M, et al. Predictors of D-Dimer Utilization in Patients Presenting With Limb Swelling in a High-Volume Tertiary Care Center. J Vasc Surg Venous Lymphat Disord. 2014;3(1):130doi: 10.1016/j.jvsv.2014.10.038.
Mousa, A., Broce, M., Kali, M., Barsoum, E., Mahrous, R., & AbuRahma, A. F. (2015). Predictors of D-Dimer Utilization in Patients Presenting With Limb Swelling in a High-Volume Tertiary Care Center. Journal of vascular surgery. Venous and lymphatic disorders, 3(1), 130. https://doi.org/10.1016/j.jvsv.2014.10.038
Mousa, A, et al. "Predictors of D-Dimer Utilization in Patients Presenting With Limb Swelling in a High-Volume Tertiary Care Center." Journal of vascular surgery. Venous and lymphatic disorders vol. 3,1 (2015): 130. doi: https://doi.org/10.1016/j.jvsv.2014.10.038
Mousa A, Broce M, Kali M, Barsoum E, Mahrous R, AbuRahma AF. Predictors of D-Dimer Utilization in Patients Presenting With Limb Swelling in a High-Volume Tertiary Care Center. J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):130. doi: 10.1016/j.jvsv.2014.10.038. Epub 2014 Dec 15. PMID: 26993724.
Copy Download .nbib Format: NLM
Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia.

Journal of pharmacy & bioallied sciences

Ahmad M, Zin CS, Ab Rahman AF.
PMID: 33828370
J Pharm Bioallied Sci. 2020 Nov;12:S737-S742. doi: 10.4103/jpbs.JPBS_298_19. Epub 2020 Nov 05.

INTRODUCTION: Patients receiving continuous ambulatory peritoneal dialysis (CAPD) are commonly associated with peritonitis. However, little is known about the utilization of antibiotics for the treatment of peritonitis in these patients.OBJECTIVES: This study aimed to evaluate the patterns of intraperitoneal...

Cite
Ahmad M, Zin CS, Ab Rahman AF. Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia. J Pharm Bioallied Sci. 2020;12:S737-S742doi: 10.4103/jpbs.JPBS_298_19.
Ahmad, M., Zin, C. S., & Ab Rahman, A. F. (2020). Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia. Journal of pharmacy & bioallied sciences, 12S737-S742. https://doi.org/10.4103/jpbs.JPBS_298_19
Ahmad, Mastura, et al. "Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia." Journal of pharmacy & bioallied sciences vol. 12 (2020): S737-S742. doi: https://doi.org/10.4103/jpbs.JPBS_298_19
Ahmad M, Zin CS, Ab Rahman AF. Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia. J Pharm Bioallied Sci. 2020 Nov;12:S737-S742. doi: 10.4103/jpbs.JPBS_298_19. Epub 2020 Nov 05. PMID: 33828370; PMCID: PMC8021038.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 41 entries